Applied Cell Biology Research Institute, Kirkland, WA, USA) and a human immortalized pancreatic ductal epithelial cell line (HPDE6-E6E7 clone 6
Recently, we found that triagonist-induced enhancement of insulin secretion exceeds levels observed with the loose co-administration of the three individual agonists in murine islets [9]
Hanmi Pharmaceutical is also preparing to commercialize its self-developed GLP-1based obesity treatment efpeglenatide and is pursuing regulatory procedures with the aim of launching the drug as early as the second half of this year
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a natural protein found in human gastric juice
A: Yes, we offer comprehensive solutions: medical weight management, endoscopic bariatric procedures, laparoscopic gastric banding, and laparoscopic sleeve gastrectomy
Pfizer's berobenatide is in Phase 3 with Phase 2b data showing weight loss in the high teens